MedTrace Logo

Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.

NCT05228197 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2025-01-22

No results posted yet for this study

Summary

The primary objective is to determine whether the Galen Prostate AI system has sufficient diagnostic accuracy and health economic value to be used for triage of pathology slides within the NHS.

Conditions

  • Prostatic Neoplasms

Interventions

DIAGNOSTIC_TEST

Biopsy & Imaging

H\&E stained prostate biopsy slides from standard of care treatment

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Imperial College London

    lead OTHER

Principal Investigators

  • Hashim U Ahmed · Imperial College London

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-11
Primary Completion
2024-08-31
Completion
2025-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05228197 on ClinicalTrials.gov